Remicade Infliximab Injection 100 Mg

Salt Composition Infliximab 100 mg
Dosage Form Injection
Origin of Medicine Imported
Life Span 2 years from manufacturing date
Pacakaging (Quantity Per Box) 1 vial per box
Packaging Type Glass vial
Indication Rheumatoid arthritis, Crohns disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis
Click to View more
Share Your Product:

Request to Call Back Send Inquiry

Remicade Infliximab Injection 100 Mg Price And Quantity

Stability After Reconstitution Stable for 24 hours at 2C to 8C
Regulatory Approval FDA and EMA approved for specified indications
Marketed By Janssen Pharmaceuticals
Reconstitution Diluent Sterile Water for Injection (SWFI)
Therapeutic Class Monoclonal Antibody
Concentration After Reconstitution 10 mg/mL infliximab
Excipients Sucrose, polysorbate 80, monobasic sodium phosphate, dibasic sodium phosphate
Administration Route Intravenous infusion only
Prescription Status Prescription-only medication
Warnings & Precautions Risk of tuberculosis, serious infections, infusion reactions, malignancy
Contraindications Serious infections, hypersensitivity to infliximab or excipients
Appearance White to off-white lyophilized powder
Adverse Effects Infusion reactions, increased risk of infections, headache, abdominal pain, nausea

Physical Form Lyophilized Powder for Solution for Injection
Origin of Medicine Imported
Quantity 100 mg per vial
Recommended For Adults and pediatric patients with autoimmune diseases such as rheumatoid arthritis, Crohns disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis
Salt Composition Infliximab 100 mg
Dosage Form Injection
Storage Instructions Store at 2C to 8C (Refrigerated); do not freeze
Brand Name Remicade
Drug Type Allopathic
Suitable For Adults and children as prescribed
Dosage As directed by physician, typically based on body weight and disease indication
Indication Rheumatoid arthritis, Crohns disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis
Dosage Guidelines Reconstitute and administer as intravenous infusion under medical supervision
Life Span 2 years from manufacturing date
Function Tumor Necrosis Factor (TNF) alpha inhibitor; immunosuppressant
Packaging Type Glass vial
Ingredients Infliximab
Pacakaging (Quantity Per Box) 1 vial per box

Stability After Reconstitution Stable for 24 hours at 2C to 8C
Regulatory Approval FDA and EMA approved for specified indications
Marketed By Janssen Pharmaceuticals
Reconstitution Diluent Sterile Water for Injection (SWFI)
Therapeutic Class Monoclonal Antibody
Concentration After Reconstitution 10 mg/mL infliximab
Excipients Sucrose, polysorbate 80, monobasic sodium phosphate, dibasic sodium phosphate
Administration Route Intravenous infusion only
Prescription Status Prescription-only medication
Warnings & Precautions Risk of tuberculosis, serious infections, infusion reactions, malignancy
Contraindications Serious infections, hypersensitivity to infliximab or excipients
Appearance White to off-white lyophilized powder
Adverse Effects Infusion reactions, increased risk of infections, headache, abdominal pain, nausea